- Home
- FLS vs CORT Comparison
FLS vs CORT Comparison
Compare FLS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLS
- CORT
- Stock Information
- Founded
- FLS 1790
- CORT 1998
- Country
- FLS United States
- CORT United States
- Employees
- FLS N/A
- CORT N/A
- Industry
- FLS Fluid Controls
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- FLS Industrials
- CORT Health Care
- Exchange
- FLS Nasdaq
- CORT Nasdaq
- Market Cap
- FLS 8.3B
- CORT 7.1B
- IPO Year
- FLS N/A
- CORT N/A
- Fundamental
- Price
- FLS $50.83
- CORT $72.14
- Analyst Decision
- FLS Strong Buy
- CORT Strong Buy
- Analyst Count
- FLS 9
- CORT 4
- Target Price
- FLS $64.11
- CORT $142.00
- AVG Volume (30 Days)
- FLS 1.8M
- CORT 1.4M
- Earning Date
- FLS 04-29-2025
- CORT 05-05-2025
- Dividend Yield
- FLS 1.65%
- CORT N/A
- EPS Growth
- FLS 20.22
- CORT 8.36
- EPS
- FLS 2.14
- CORT 1.14
- Revenue
- FLS $4,614,870,000.00
- CORT $685,446,000.00
- Revenue This Year
- FLS $6.43
- CORT $36.81
- Revenue Next Year
- FLS $3.77
- CORT $32.00
- P/E Ratio
- FLS $23.75
- CORT $63.13
- Revenue Growth
- FLS 4.23
- CORT 30.93
- 52 Week Low
- FLS $37.34
- CORT $25.35
- 52 Week High
- FLS $65.08
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- FLS 66.94
- CORT 53.35
- Support Level
- FLS $46.34
- CORT $68.92
- Resistance Level
- FLS $47.89
- CORT $75.41
- Average True Range (ATR)
- FLS 1.42
- CORT 3.83
- MACD
- FLS 0.86
- CORT -0.13
- Stochastic Oscillator
- FLS 91.63
- CORT 61.25
About FLS Flowserve Corporation
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. In addition, Flowserve has a network of Quick Response Centers to provide aftermarket equipment services. The aftermarket services help customers with installation, diagnostics, repair, and retrofitting. Sales are roughly split across many regions, with North America and Europe contributing the majority of total revenue.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.